Jindřich Špinar
Publications by Year
Research Areas
Diabetes Treatment and Management, Heart Failure Treatment and Management, Atrial Fibrillation Management and Outcomes, Cardiovascular Function and Risk Factors, Antiplatelet Therapy and Cardiovascular Diseases
Most-Cited Works
- → 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk(2019)4,829 cited
- → Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure(2020)4,820 cited
- → Empagliflozin in Heart Failure with a Preserved Ejection Fraction(2021)4,371 cited
- → Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction(2015)1,937 cited
- → Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus(2017)420 cited
- → Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease(2016)385 cited
- → Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial(2016)287 cited
- → Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World(2013)250 cited
- → Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality(2016)201 cited
- → Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients(2018)178 cited